Did You Know?

Editor’s Picks

Latest News

CLS Americas and URN Announce First Patient Treated in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”

Minimally Invasive, Outpatient Treatment Designed for Office or ClinicIRVINE, Calif. and MIAMI, April 20, 2022 (GLOBE NEWSWIRE) -- CLS Americas,...

error: Content is protected !!